Joji Nagasawa

Novel HER2 selective tyrosine kinase inhibitor, TAK‐165, inhibits bladder, kidney and androgen‐independent prostate cancer in vitro and in vivo

Mikio Namiki, Atsushi Mizokami, Sei Yoshida, 2006, International journal of urology : official journal of the Japanese Urological Association.